Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968405 · ClinicalTrials.gov registry record · NA
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
A NA study of Osteoarthritis Shoulder and Avascular Necrosis of the Head of Humerus, sponsored by Catalyst OrthoScience.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 3
- Study locations
NCT04968405: Recruiting NA study of Osteoarthritis Shoulder and Avascular Necrosis of the Head of Humerus, sponsored by Catalyst OrthoScience.
NCT04968405 is a NA study of Osteoarthritis Shoulder and Avascular Necrosis of the Head of Humerus that is actively recruiting participants, run by Catalyst OrthoScience. The registered enrollment target is 90 participants, below the 359-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968405, a NA study of Osteoarthritis Shoulder and Avascular Necrosis of the Head of Humerus, is actively recruiting participants, sponsored by Catalyst OrthoScience.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 3
- Study locations
Study Summary
Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.
Primary Outcome
Change from baseline in patient reported outcome scores using the ASES
Conditions Studied
Interventions
- DEVICE Catalyst CSR Total Shoulder System
Study Locations (3)
Michigan
- Beaumont Hospital Royal Oak - Royal Oak
Oregon
- Kaiser Permanente Northwest Center for Health Research - Portland
Rhode Island
- Lifespan/University Orthopedics - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT04968405 shows while recruiting
NCT04968405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 359-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Osteoarthritis Shoulder appearing as the primary indexed condition, and to 1 intervention - of which Catalyst CSR Total Shoulder System is the first listed.
NCT04968405 reports a single indexed study location in Michigan, Oregon, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT04968405 about?
NCT04968405 is a clinical study titled "Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty". Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.
What is the current status of trial NCT04968405?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-07-22. Estimated completion is 2026-02-28.
What conditions does trial NCT04968405 study?
This clinical trial studies the following conditions: Osteoarthritis Shoulder, Avascular Necrosis of the Head of Humerus, Rheumatoid Arthritis Shoulder.
What interventions are being tested in trial NCT04968405?
The interventions under investigation include: Catalyst CSR Total Shoulder System (DEVICE).
Who is sponsoring clinical trial NCT04968405?
This trial is sponsored by Catalyst OrthoScience, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04968405 being conducted?
This trial has 3 study locations across Michigan, Oregon, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04968405's enrollment target sits among peer trials
90 7th of 8 higher than 2 of 8 other Osteoarthritis Shoulder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis Shoulder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
RECRUITING · NA
-
Effectiveness of Occupation-Based Intervention Compared With Therapeutic Exercise for Older Adults With Shoulder OA.
COMPLETED · NA
-
FX Shoulder Solutions Retrospective / Prospective Clinical Study
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
-
FX Shoulder Prospective Clinical Study
RECRUITING
-
Embo Registry; National Registry for Artery Embolization
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI